Molecular basis for checkpoints in the CD8 T cell response: Tolerance versus activation

Seminars in Immunology

Volumn 19, Issue 3, 2007, Pages 153-161

  Mescher, Matthew F ^a   Agarwal, Pujya ^a   Casey, Kerry A ^a   Hammerbeck, Christopher D ^a   Xiao, Zhengguo ^a   Curtsinger, Julie M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Activation; Anergy; CD8 T lymphocyte; Differentiation; Peripheral tolerance

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA INTERFERON; BETA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2;

AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; EFFECTOR CELL; GRAFT REJECTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD28; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS;

EID: 34249293041     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.02.007     Document Type: Review

References (81)

1. Anderson M.S., Venanzi E.S., Chen Z., Berzins S.P., Benoist C., and Mathis D. The cellular mechanism of aire control of T cell tolerance. Immunity 23 2 (2005) 227-239
2. Ohashi P., Oehen S., Buerki K., Pircher H., Ohashi C., Odermatt B., et al. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65 (1991) 305-317
3. Redmond W.L., and Sherman L.A. Peripheral tolerance in CD8 T lymphocytes. Immunity 22 (2005) 275-284
4. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143 (1976) 1283-1288
5. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19 (2001) 47-64
6. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Ann Rev Immunol 21 (2003) 685-711
7. Bennett S.R.M., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F.A.P., and Heath W.R. Help for cytotoxic T-cell responses is mediated by CD40 signaling. Nature 393 (1998) 478-480
8. Ridge J.P., DiRosa F., and Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393 (1998) 474-478
9. Schoenberger S.P., Toes R.E.M., van der Voort E.I.H., Offringa R., and Melief C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393 (1998) 480-483
10. Albert M.L., Jegathesan M., and Darnell R.B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2 (2001) 1010-1017
11. Fujii S.-i., Liu K., Smith C., Bonito A.J., and Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199 12 (2004) 1607-1618
12. Hernandez J., Aung S., Marquardt K., and Sherman L.A. Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med 196 3 (2002) 323-333
13. Allison J.P. CD28-B7 interactions in T cell activation. Curr Opin Immunol 6 (1994) 414-419
14. Janeway C.A., and Bottomly K. Signals and signs for lymphocyte responses. Cell 76 (1994) 275-285
15. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Ann Rev Immunol 14 (1996) 233
16. Mueller D., Jenkins M., and Schwartz R. Clonal expansion vs functional clonal inactivation. Ann Rev Immunol 7 (1989) 445-480
17. + T cells. J Immunol 162 (1999) 3256-3262
18. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D.C., and Mescher M.F. Cutting edge: type I interferons provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 174 (2005) 4465-4469
19. Gately M.K., Wolitzky A.G., Quinn P.M., and Chizzonite R. Regulation of human cytolytic lymphocyte responses by IL-12. Cell Immunol 143 (1992) 127-142
20. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 70 (1998) 83
21. Marrack P., Kappler J., and Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 189 3 (1999) 521-530
22. Nguyen K.B., Watford W.T., Salomon R., Hofmann S.R., Pien G.C., Morinobu A., et al. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297 5589 (2002) 2063-2066
23. Aichele P., Brduscha-Reim K., Zinkernagel R., Hengartner H., and Pircher H. T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med 182 (1995) 261-266
24. Aichele P., Kyburz D., Ohashi P.S., Odermatt B., Zinkernagel R.M., Hengartner H., et al. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci USA 91 (1994) 444
25. Kyburz D., Aichele P., Speiser D., Hengartner H., Zinkernagel R., and Pircher H. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 23 (1993) 1956-1962
26. Curtsinger J.M., Lins D.C., and Mescher M.F. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 197 (2003) 1141-1151
27. + T cells in vivo. J Immunol 163 (1999) 2561-2567
28. Aichele P., Unsoeld H., Koshella M., Schweier O., Kalinke U., and Vucikuja S. Cutting Edge: CD8 T cells specific for lymphocytic choriomeningitis virus require Type I IFN receptor for clonal expansion. J Immunol 176 (2006) 4525-4529
29. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., and Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202 (2005) 637-650
30. Le Bon A., Durand V., Kamphuis E., Thompson C., Bulfone-Paus S., Rossmann C., et al. Direct stimulation of T cells by Type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 176 (2006) 4682-4689
31. Thompson L.J., Kolumam G.A., Thomas S., and Murali-Krishna K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 177 (2006) 1746-1754
32. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184 2 (1996) 747-752
33. Filatenkov A.A., Jacovetty E.L., Fischer U.B., Curtsinger J.M., Mescher M.F., and Ingulli E. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection. J Immunol 174 (2005) 6909-6917
34. van Stipdonk M.J., Lemmens E.E., and Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2 5 (2001) 423-429
35. Curtsinger J.M., Johnson C.M., and Mescher M.F. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171 (2003) 5165-5171
36. Kaplan M.H., Sun Y.L., Hoey T., and Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382 (1996) 174-177
37. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., et al. Requirement for Stat4 in interleukin-12-mediated resposes of natural killer cells and T cells. Nature 382 (1996) 171-174
38. Murphy T.L., Geissal E.D., Farrar J.D., and Murphy K.M. Role of the Stat4 N domain in recptor proximal tyrosine phosphorylation. Mol Cell Biol 20 (2000) 7121-7131
39. Croft M., Carter L., Swain S.L., and Dutton R.W. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180 (1994) 1715-1728
40. Haring J.S., Badovinac V.P., and Harty J.T. Inflaming the CD8+ T cell response. Immunity 25 (2006) 19-29
41. Badovinac V.P., Tvinnereim A.R., and Harty J.T. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science 290 (2000) 1354-1358
42. Whitmire J.K., Tan J.T., and Whitton J.L. IFN-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J Exp Med 201 (2005) 1053-1059
43. Sercan O., Hammerling G.J., Arnold B., and Schuler T. Innate immune cells contribute to the IFN-gamma-dependent regulation of antigen-specific CD8+ T cell homeostasis. J Immunol 176 (2006) 735-739
44. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 6808 (2000) 57-63
45. Valenzuela J., Hammerbeck C.D., and Mescher M.F. Cutting Edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells. J Immunol 174 (2005) 600-604
46. Rocha B., Grandien A., and Freitas A. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med 181 3 (1995) 993-1003
47. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J.D., Suresh M., Altman J.D., et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188 (1999) 2205-2213
48. Deeths M.J., Kedl R.M., and Mescher M.F. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 163 1 (1999) 102-110
49. Jenkins M., and Schwartz R. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165 (1987) 302-319
50. Mueller D., and Jenkins M. Molecular mechanisms underlying function T-cell unresponsiveness. Curr Opin Immunol 7 (1995) 375-381
51. Tham E.L., Shrikant P., and Mescher M.F. Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. J Immunol 168 (2002) 1190-1197
52. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251 (1991) 1228-1231
53. Kaech S.M., Hemby S., Kersh E., and Ahmed R. Molecular and functional profiling of memory CD8 T Cell differentiation. Cell 111 6 (2002) 837-851
54. Shrikant P., and Mescher M.F. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J Immunol 162 (1999) 2858-2866
55. Wherry E.J., Barber D.L., Kaech S.M., Blattman J.N., and Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. PNAS 101 45 (2004) 16004-16009
56. Shrikant P., and Mescher M.F. Opposing effects of interleukin-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. J Immunol 169 (2002) 1753-1759
57. Blattman J.N., Grayson J.M., Wherry E.J., Kaech S.M., Smith K.A., and Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 9 5 (2003) 540-547
58. Shrikant P., Khoruts A., and Mescher M.F. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell and IL-2-dependent mechanism. Immunity 11 (1999) 483-493
59. Buentke E., Mathiot M., Tolaini M., Di Santo J., Zamoyska R., and Seddon B. Do CD8 effector T cells need IL-7R expression to become resting memory cells?. Blood 108 (2006) 1949-1956
60. Prlic M., Lefrancois L., and Jameson S.C. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J Exp Med 195 (2002) F49-F52
61. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., and Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4 12 (2003) 1191-1198
62. Lacombe M.H., Hardy M.P., Rooney J., and Labrecque N. IL-7 receptor expression levels do not identify CD8 memory T lymphocyte precursors following peptide immunization. J Immunol 175 (2005) 4400-4407
63. Fields P.E., Gajewski T.F., and Fitch F.W. Blocked Ras activation in anergic CD4+ T cells. Science 271 (1996) 1276-1278
64. DeSilva D.R., Feeser W.S., Tancula E.J., and Scherle P.A. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. J Exp Med 183 5 (1996) 2017-2023
65. + T cells. Science 271 (1996) 1272-1276
66. Kang S.M., Beverly B., Tran A.C., Brorson K., Schwartz R.H., and Lenardo M.J. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 21 (1992) 1134-1138
67. Zhang J., Salojin K.V., Gao J.X., Cameron M.J., Bergerot I., and Delovitch T.L. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J Immunol 162 (1999) 3819-3829
68. Tham E.L., and Mescher M.F. Signaling alterations in activation-induced non-responsive (AINR) CD8 T cells. J Immunol 167 (2001) 2040-2048
69. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., and Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77 (1994) 727-736
70. Uhlin M., Masucci M.G., and Levitsky V. Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci USA 102 (2005) 9264-9269
71. Mueller D.L. E3 ubiquitin ligases as T cell anergy factors. Nat Immunol 5 (2004) 883-890
72. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Ann Rev Immunol 23 (2005) 515-548
73. Okazaki T., and Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 27 (2006) 195-201
74. Nishimura H., Nose M., Hiai H., Minato N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 (1999) 141-151
75. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
76. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
77. Carter L.L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., et al. PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2. Eur J Immunol 32 (2002) 634-643
78. Lactchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci USA 101 (2004) 10691-10696
79. Banchereau J., and Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 (2006) 383-392
80. Theofilopoulos A.N., Baccala R., Beutler B., and Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23 (2005) 307-336
81. O'Shea J.J., Park H., Pesu M., Borie D., and Changelian P. New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway. Curr Op Rheumatol 17 (2005) 305-311